← Evidence map

ArticleJHEP reports : innovation in hepatology2026

Reply to: "Are FIB-4 and liver stiffness measurement interchangeable for HCC risk stratification in MASLD?"

Georg Semmler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42323129